Measles still remains a major cause of childhood morbidity and mortality worldwide. Measles
virus (MV) vaccines are highly successful, but the mechanism underlying their efficacy has …

The filoviruses, including Marburg and Ebola, express a single glycoprotein on their surface,
termed GP, which is responsible for attachment and entry of target cells. Filovirus GPs differ …

In late 2022, various Omicron subvariants emerged and cocirculated worldwide. These
variants convergently acquired amino acid substitutions at critical residues in the spike protein, …

Potent neutralizing SARS-CoV-2 antibodies often target the spike protein receptor-binding
site (RBS), but the variability of RBS epitopes hampers broad neutralization of multiple …

Administration of convalescent plasma or neutralizing monoclonal antibodies (mAbs) is a
potent therapeutic option for coronavirus disease 2019 (COVID-19) caused by severe acute …

In late 2022, SARS-CoV-2 Omicron subvariants have become highly diversified, and XBB is
spreading rapidly around the world. Our phylogenetic analyses suggested that XBB …

After the global spread of the SARS-CoV-2 Omicron BA.2, some BA.2 subvariants, including
BA.2.9.1, BA.2.11, BA.2.12.1, BA.4, and BA.5, emerged in multiple countries. Our statistical …

Measles virus, a major cause of childhood morbidity and mortality worldwide, predominantly
infects immune cells using signaling lymphocyte activation molecule (SLAM) as a cellular …

Antiviral treatments targeting the coronavirus disease 2019 are urgently required. We
screened a panel of already approved drugs in a cell culture model of severe acute respiratory …

The mechanisms by which neutralizing antibodies inhibit Marburg virus (MARV) are not known.
We isolated a panel of neutralizing antibodies from a human MARV survivor that bind to …